Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy

by Xiao Han, Yao Wang, Jianshu Wei, Weidong Han
Published 2019-11-01

Target selection for CAR-T therapy

by Jianshu Wei, Xiao Han, Jian Bo, Weidong Han
Published 2019-06-01

PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity

by Jianshu Wei, Can Luo, Yao Wang, Yelei Guo, Hanren Dai, Chuan Tong, Dongdong Ti, Zhiqiang Wu, Weidong Han
Published 2019-08-01

Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming

by Yao Wang, Chuan Tong, Hanren Dai, Zhiqiang Wu, Xiao Han, Yelei Guo, Deyun Chen, Jianshu Wei, Dongdong Ti, Zongzhi Liu, Qian Mei, Xiang Li, Liang Dong, Jing Nie, Yajing Zhang, Weidong Han
Published 2021-01-01